|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: EPT1 |
Gene summary for EPT1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | EPT1 | Gene ID | 85465 |
| Gene name | selenoprotein I | |
| Gene Alias | EPT1 | |
| Cytomap | 2p23.3 | |
| Gene Type | protein-coding | GO ID | GO:0006629 | UniProtAcc | Q9C0D9 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 85465 | EPT1 | P1T-E | Human | Esophagus | ESCC | 6.27e-10 | 4.71e-01 | 0.0875 |
| 85465 | EPT1 | P2T-E | Human | Esophagus | ESCC | 4.77e-42 | 8.48e-01 | 0.1177 |
| 85465 | EPT1 | P4T-E | Human | Esophagus | ESCC | 5.57e-32 | 7.27e-01 | 0.1323 |
| 85465 | EPT1 | P5T-E | Human | Esophagus | ESCC | 1.39e-32 | 6.31e-01 | 0.1327 |
| 85465 | EPT1 | P8T-E | Human | Esophagus | ESCC | 3.45e-09 | 1.59e-01 | 0.0889 |
| 85465 | EPT1 | P9T-E | Human | Esophagus | ESCC | 5.16e-24 | 4.41e-01 | 0.1131 |
| 85465 | EPT1 | P10T-E | Human | Esophagus | ESCC | 3.20e-29 | 4.84e-01 | 0.116 |
| 85465 | EPT1 | P11T-E | Human | Esophagus | ESCC | 4.82e-13 | 4.84e-01 | 0.1426 |
| 85465 | EPT1 | P12T-E | Human | Esophagus | ESCC | 4.50e-30 | 5.10e-01 | 0.1122 |
| 85465 | EPT1 | P15T-E | Human | Esophagus | ESCC | 4.49e-41 | 9.13e-01 | 0.1149 |
| 85465 | EPT1 | P16T-E | Human | Esophagus | ESCC | 1.62e-28 | 5.36e-01 | 0.1153 |
| 85465 | EPT1 | P17T-E | Human | Esophagus | ESCC | 2.26e-04 | 2.00e-01 | 0.1278 |
| 85465 | EPT1 | P19T-E | Human | Esophagus | ESCC | 1.67e-04 | 3.80e-01 | 0.1662 |
| 85465 | EPT1 | P20T-E | Human | Esophagus | ESCC | 1.56e-26 | 5.40e-01 | 0.1124 |
| 85465 | EPT1 | P21T-E | Human | Esophagus | ESCC | 1.75e-20 | 4.27e-01 | 0.1617 |
| 85465 | EPT1 | P22T-E | Human | Esophagus | ESCC | 5.53e-50 | 8.82e-01 | 0.1236 |
| 85465 | EPT1 | P23T-E | Human | Esophagus | ESCC | 1.21e-25 | 6.03e-01 | 0.108 |
| 85465 | EPT1 | P24T-E | Human | Esophagus | ESCC | 6.47e-18 | 5.11e-01 | 0.1287 |
| 85465 | EPT1 | P26T-E | Human | Esophagus | ESCC | 1.21e-52 | 8.34e-01 | 0.1276 |
| 85465 | EPT1 | P27T-E | Human | Esophagus | ESCC | 1.04e-38 | 6.56e-01 | 0.1055 |
| Page: 1 2 3 4 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00086544 | Esophagus | ESCC | phospholipid biosynthetic process | 162/8552 | 253/18723 | 2.59e-09 | 5.73e-08 | 162 |
| GO:00464744 | Esophagus | ESCC | glycerophospholipid biosynthetic process | 135/8552 | 211/18723 | 5.75e-08 | 1.02e-06 | 135 |
| GO:00450175 | Esophagus | ESCC | glycerolipid biosynthetic process | 154/8552 | 252/18723 | 5.20e-07 | 6.96e-06 | 154 |
| GO:00066446 | Esophagus | ESCC | phospholipid metabolic process | 218/8552 | 383/18723 | 5.37e-06 | 5.59e-05 | 218 |
| GO:00066561 | Esophagus | ESCC | phosphatidylcholine biosynthetic process | 24/8552 | 29/18723 | 4.50e-05 | 3.55e-04 | 24 |
| GO:00066505 | Esophagus | ESCC | glycerophospholipid metabolic process | 174/8552 | 306/18723 | 4.92e-05 | 3.85e-04 | 174 |
| GO:0006646 | Esophagus | ESCC | phosphatidylethanolamine biosynthetic process | 10/8552 | 10/18723 | 3.94e-04 | 2.26e-03 | 10 |
| GO:00464864 | Esophagus | ESCC | glycerolipid metabolic process | 211/8552 | 392/18723 | 6.51e-04 | 3.46e-03 | 211 |
| GO:00086543 | Oral cavity | OSCC | phospholipid biosynthetic process | 130/7305 | 253/18723 | 3.96e-05 | 3.46e-04 | 130 |
| GO:00464743 | Oral cavity | OSCC | glycerophospholipid biosynthetic process | 102/7305 | 211/18723 | 3.50e-03 | 1.48e-02 | 102 |
| GO:00066445 | Oral cavity | OSCC | phospholipid metabolic process | 175/7305 | 383/18723 | 4.21e-03 | 1.71e-02 | 175 |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |